HYLORIS PHARMACEUTIC

HYL
Real-time Euronext Bruxelles - 10:04 2022-12-07 am EST
13.38 EUR -0.15%

Turn to zoom
Prev.13.40000000
Open13.36000000
High13.40000000
Low13.10000000
Volume2 239
Latest news
11/23
11/22
11/22
11/22
Chart HYLORIS PHARMACEUTICALS SA
Technical analysis trends
Short TermMid-TermLong Term
TrendNeutralNeutralBearish
Resistance14,314,915,1
Spread/Res.-6,2%-10%-11%
Spread/Supp.3,7%8,8%7,0%
Support12,912,312,5
Financials
Sales 2022 5,00 M 5,26 M 5,26 M
Net income 2022 -12,0 M -12,6 M -12,6 M
Net cash 2022 26,0 M 27,4 M 27,4 M
P/E ratio 2022 -29,8x
Yield 2022 -
Capitalization 359 M 378 M 378 M
EV / Sales 2022 66,6x
EV / Sales 2023 31,6x
Nbr of Employees 21
Free-Float 52,2%
Company
Hyloris Pharmaceuticals SA is a specialty biopharma company identifying and unlocking hidden potential in existing medications for the benefit of patients and the healthcare system. Hyloris applies its knowhow and technological innovations to existing pharmaceuticals and has built a broad...
Sector :
Other Pharmaceuticals
Calendar :
2023-03-16 Earnings Release
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 1
Last Close Price 13,40 €
Average target price 20,00 €
Spread / Average Target 49,3%